Zuranolone
| CAS No. | 1632051-40-1 |
|---|---|
| MDL No. | MFCD31619241 |
| MF | C25H35N3O2 |
| MW | 409.60 |
| InChI Key | HARRKNSQXBRBGZ-GVKWWOCJSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Zuranolone is a 3-hydroxy steroid, specifically a 5β-19-norpregnane derivative substituted with hydroxy, methyl, oxo, and 4-cyano-1H-pyrazol-1-yl groups at positions 3, 3, 20, and 21, respectively. It is a positive allosteric modulator of the GABAA receptor developed by Sage Therapeutics and Biogen for the treatment of postpartum depression in adults. It functions as an antidepressant, GABA modulator, and anticonvulsant. It is classified as a nitrile, a pyrazole, a 3-hydroxy steroid, and a 20-oxo steroid.
| CAS No. | 1632051-40-1 |
|---|---|
| Product Name | Zuranolone |
Biological Targets
GABRA1·GABRB2·GABRG2·GABRB3·GABRA4·
Associated Conditions
postpartum depression·major depressive disorder·essential tremor·Parkinson disease·mood disorder·
* The information provided here is compiled from public sources and is for reference only.
